This compound is a ruthenium-based asymmetric hydrogenation catalyst, commonly used in research laboratories for enantioselective synthesis. Its structure features a chiral sulfonylazanide ligand coordinated to ruthenium, along with mesitylene as a stabilizing ligand.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 174813-81-1
Dichloro[(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl]ruthenium (II)
research compound
Chloro[(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl](p-cymene)ruthenium(II) chloride
research compound
5'-Deoxy-5'-methylthioadenosine-d3
research compound
(4S)-Methyl-[1,3,2]dioxathiolane 2,2-dioxide
research compound
Tribromoisocyanuric acid
research compound
6-(tert-butyl)pyrimidine-2,4-diamine
research compound
Chloro[[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido](mesitylene)ruthenium(II)
research compound
Chloro[[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](pentafluorophenylsulfonyl)amido](p-cymene)ruthenium(II)
research compound
[(1S,2S)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1,3,5-trimethylbenzene
XBNBOGZUDCYNOJ-XCPIVNJJSA-M
CC1=CC=C(C=C1)S(=O)(=O)[N-][C@@H](C2=CC=CC=C2)[C@H](C3=CC=CC=C3)N.CC1=CC(=CC(=C1)C)C.Cl[Ru+]
—